BestBits

BestBits of the Literature is a synopsis of current literature in Pediatric Hematology & Oncology.

[BestBits @bestbitsca]

I'm live streaming on @YouTube. Come watch: https://t.co/boShlfYUek

[BestBits @bestbitsca]

The March/April issue of https://t.co/PdDWFiKo6w is now available! We feature articles on radiation to mets in neuroblastoma for local control, innovative CRISPR/Cas9 editing of the beta-globin gene to increase HbF in beta thal and SCD, and on gene therapy in hemophilia B. Enjoy!

[BestBits @bestbitsca]

The January/February issue of https://t.co/PdDWFiKo6w is now available! We are featuring reports on the AIEOP-BFM ALL 2000 trial with reduced delayed intensification, the AREN0532 protocol for stage III favourable histology Wilms tumor, and the HERBY trial on bevacizumab in HGG.

[BestBits @bestbitsca]

and two manuscripts on how to identify patients at increased risk for:
- Subsequent CNS Tumors in Childhood Cancer Survivors: clinical and genetic risk factors;
- A new self-administered pediatric bleeding questionnaire as a screening tool for von Willebrand disease.
Enjoy!

[BestBits @bestbitsca]

The latest BestBits issue of Oct/ Nov 2017 is out! Please have a look at https://t.co/NUtYYYO2wi.
Our highlights are:
- REMAP: A Framework for Goals of Care Conversations: a tool to promote patient-centered decision making...

[BestBits @bestbitsca]

The virtual journal club has started: Join in!
For BMT: vitamin D before HSCT: another hype?
L&L: do we have to check genetic polymorphisms before gemtuzumab treatment in AML?
Heme: are young and beautiful red cells better?
And solid tu: Are 45Gy enough in Gr.III orbital RMS?

[BestBits @bestbitsca]

The August/September edition of BestBits.ca is now available online as a free download on https://t.co/NUtYYYO2wi
We feature reviews on: pre-HSCT vitamin D deficiency, genetic polymorphisms in gemtuzumab treatment, and the effect of ageing in red cells transfusions.

[BestBits @bestbitsca]

All of this and much more on bestbits.ca. Become a participant or reviewer and join the Virtual Journal Club... coming up soon!

[BestBits @bestbitsca]

The COG report on the effect of reduced DOXO in Down syndrome-associated AML. And a report on removal of ETOPO in intraocular group B RB.

[BestBits @bestbitsca]

The highlights this month: Chemotherapy and its role in subsequent malignancies: the Dutch report on the effect of DOXO and CY.

[BestBits @bestbitsca]

Check out the June/ July edition of BestBits.ca and stay informed about what's happening in Peds Hem/Onc...

[BestBits @bestbitsca]

This issue's highlights: reduction of toxicity in germ cell tumors, discontinuation of imatinib in CML, and administration of 6-MP in ALL

[BestBits @bestbitsca]

Check out the latest issue of BestBits, the Hem/ Onc literature review: The April/May edition of BestBits.ca is available at best bits.ca

[BestBits @bestbitsca]

Thanks to all the contributors who participated in the journal review for the February/ March issue.

[BestBits @bestbitsca]

The February/ March BestBits.ca issue is out: check it out on https://t.co/0Wq0LlHTDN.

[BestBits @bestbitsca]

Stay tuned... The February/ March edition of BestBits.ca is in the press and will be released soon!

[BestBits @bestbitsca]

Round 1 has been assigned to the reviewers. We are excited to get back summaries of the most important articles by April 21st.

[BestBits @bestbitsca]

Don't forget to register to be a #bestbits contributor - deadline for the first issue is today!

[BestBits @bestbitsca]

Cool - time to tweet more! https://t.co/rwBnYn7fyF

[JAMA Oncology @JAMAOnc]

Hematologist-oncologists on Twitter received a median $1644.77 in general payments, $11,064.21 in research payments https://t.co/pAKwguqxYw